Volume: 25 Issue: 8

1. Exploration and expectation on treatment strategies of central nervous system diseases based on transporters at blood-brain barrier Page:953—960
2. Targeting DNA damage response in tumor therapy Page:943—952
3. Effects of aripiprazole combined with duloxetine on the treatment effect and VEGF level in patients with refractory depression Page:937—942
4. Efficacy and safety of XELOX therapy in comparison with capecitabine monotherapy in adjuvant chemotherapy for elderly patients with colorectal cancer Page:926—936
5. Potential inappropriate medications use in the geriatric condition of frailty based on STOPPFrail criteria: A cross-sectional study Page:916—925
6. Bioequivalence of fluconazole capsules in healthy Chinese subjects Page:910—915
7. Pharmacokinetics and pharmacodynamics of (S)-pantoprazole sodium enteric-coated tablets in healthy subjects Page:903—909
8. Tocilizumab related adverse events: A cross-section analysis of FDA Adverse Event Reporting System Page:895—902
9. Brief analysis on the measures for the management of instruments and equipment in phase drug clinical trials Page:890—894
10. Comparison of policies and guidelines regarding using of real world data/real word evidence Page:878—889
11. Drug clinical trial of COVID-19 in China: A brief analysis Page:869—877
12. Experimental study on the effect of curcumin on endometriosis in rats Page:862—868
13. Effects of dexmedetomidine on renal function and serum inflammatory factors in sepsis rats Page:857—861
14. Esveratrol inhibits NLRP3 inflammasome activation in rabbits with spinal cord injury Page:850—856
15. Effects of knocking down long intergenic non-coding RNA 00467 on the prognosis of patients with lung adenocarcinoma and its mechanism Page:841—849